# The Oncologist

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/the-oncologist/

## Facts

| Field | Value |
| --- | --- |
| APC (USD) | 1,500 |
| Citations | 313,933 |
| h-index | 228 |
| Homepage | https://onlinelibrary.wiley.com/journal/1549490x |
| Open Access | true |
| ISSN-L | 1083-7159 |
| ISSNs | 1083-7159,1549-490X |
| OpenAlex ID | https://openalex.org/S15523509 |
| Publisher | AlphaMed Press |
| Works | 7,540 |

## Journal papers

Showing 12 of 40.

- [Understanding and Managing Methotrexate Nephrotoxicity](https://scholariq.org/papers/understanding-and-managing-methotrexate-nephrotoxicity/)
- [Biology and Therapeutic Advances for Pediatric Osteosarcoma](https://scholariq.org/papers/biology-and-therapeutic-advances-for-pediatric-osteosarcoma/)
- [Physical Exercise for Cancer Patients with Advanced Disease: A Randomized Controlled Trial](https://scholariq.org/papers/physical-exercise-for-cancer-patients-with-advanced-disease-a-randomized/)
- [Sarcopenia Is Associated with Quality of Life and Depression in Patients with Advanced Cancer](https://scholariq.org/papers/sarcopenia-is-associated-with-quality-of-life-and-depression-in-patients-with/)
- [Intravenous Ferric Gluconate Significantly Improves Response to Epoetin Alfa Versus Oral Iron or No Iron in Anemic Patients with Cancer Receiving Chemotherapy](https://scholariq.org/papers/intravenous-ferric-gluconate-significantly-improves-response-to-epoetin-alfa/)
- [Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance](https://scholariq.org/papers/consensus-guideline-for-use-of-glucarpidase-in-patients-with-high-dose/)
- [Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study](https://scholariq.org/papers/clinical-outcomes-of-patients-with-advanced-cancer-and-pre-existing-autoimmune/)
- [Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy](https://scholariq.org/papers/sicca-syndrome-associated-with-immune-checkpoint-inhibitor-therapy/)
- [Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data](https://scholariq.org/papers/weekly-low-dose-versus-three-weekly-high-dose-cisplatin-for-concurrent/)
- [Economic Burden for Informal Caregivers of Lung and Colorectal Cancer Patients](https://scholariq.org/papers/economic-burden-for-informal-caregivers-of-lung-and-colorectal-cancer-patients/)
- [Toward an Expert Level of Lung Cancer Detection and Classification Using a Deep Convolutional Neural Network](https://scholariq.org/papers/toward-an-expert-level-of-lung-cancer-detection-and-classification-using-a-deep/)
- [Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors \[RECIST\]) Versus RECIST 1.1 in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib](https://scholariq.org/papers/alternative-response-criteria-choi-european-association-for-the-study-of-the/)

## Journal top topics

Showing 8 of 25.

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.